iMD Companies, Inc.

OTC: ICBU · Healthcare · Medical - Diagnostics & Research

PublicHQ Rancho Cordova, FLReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

48D

FH 55DQ —GM 26SS 48

v0.1 · 45/100 weight · provisional

↑ return on assets, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

$418.4k

Employees

Market cap

$2.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income$418.4k$418.4k2025

Operating income-$178.2k-$178.2k2025

Total assets$357.8k$357.8k2025

Liabilities$2.4M$2.4M2025

Equity-$2.1M-$2.1M2025

Revenue trend

FY2018 – FY2025 · USD

$1.8M

FY18

FY19

FY20

$28.6k

FY21

$8.4k

FY22

FY23

$1.0M

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

iMD Companies, Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.

Peers · Healthcare

Accustem Sciences Inc.——Clearmind Medicine Inc.——CDT Equity Inc.——Acurx Pharmaceuticals, Inc.——

Key facts

CEORichard Wilson

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersRancho Cordova, FL

ExchangeOTC: ICBU

Employees5

IPO date1996-08-12

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.